Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
Giodini, A., Kallio, MJ, Wall, NR, Gorbsky, GJ, Tognin, S., Marchisio, PC,
Symons, M. and Altieri, DC (2002). Regulation of microtubule stability and
mitotic progression by survivin. Cancer Res. 62: 2462-2467.
Giscombe, R., Grunewald, J., Nityanand, S. and Lefvert, AK (1995). T cell
receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis.
Clin. Exp. Immunol. 101(2): 213-219.
Giuntoli, RL2, Lu, J., Kobayashi, H., Kennedy, R. and Celis, E. (2002). Direct
Costimulation of Tumorreactive CTL by Helper T Cells Potentiate Their
Proliferation, Survival, and Effector Function. Clin. Cancer Res. 8: 922-931.
Glennie, MJ and Johnson,PW (2000). Clinical trials of antibody therapy.
Immunol. Today 21(8): 403-410.
Goldberg, AL and Rock, KL (1992). Proteolysis, proteasomes and antigen
presentation. Nature 357: 375-379.
Goldschmeding, R., van der Schoot, CE, ten Bokkel Huinink, D., Hack, CE, van
den Ende, ME, Kallenberg, CG and von dem Borne, AE (1989). Wegener's
granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-
binding protein in the lysosomes of normal human neutrophils. J. Clin. Invest.
84(5): 1577-1587.
Gorelik, L., Constant, S. and Flavell, RA (2002). Mechanism of transforming
growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp.
Med. 195: 1499-1505.
Gouttefangeas, C. and Rammensee, HG (2000). Problem solving for tumor
immunotherapy. Nat. Biotechnol. 18: 491-492.
104